You are here: vision-research.eu » News

News

Phase I Trial for RGX-314 for Wet AMD Doses Fourth Cohort

Clinical-stage biotechnology company REGENXBIO Inc. announced earlier this month that it has completed dosing of the fourth cohort of six patients in a Phase I clinical trial evaluating RGX-314 for the treatment of wet age-related macular degeneration (wet AMD or nAMD).

Biologists use 'mini retinas' to better understand connection between eye and brain

IUPUI biologists are growing 'mini retinas' in the lab from stem cells to mimic the growth of the human retina.

How to work with your institution’s press office to maximize the reach of your work

Want your study to make the headlines? You can get help with that.

Second Sight Raises $5 Million in Private Placement from Chairman Gregg Williams

Second Sight Medical Products entered an agreement with entities beneficially owned by the company’s chairman, Gregg Williams, for the purchase of 3.2 million shares of common stock priced at $1.55 per share, the company announced.

IoO and Moorfields exhibit ‘medical marvels’ at Science Museum Lates

Clinician researchers from the IoO and Moorfields Eye Hospital took part in the Science Museum’s ‘Medicine’ themed Lates – celebrating medical achievements from the NHS over the past 70 years

Is too much screen time harming children's vision?

As children spend more time tethered to screens, there is increasing concern about potential harm to their visual development.

Top tips for building and maintaining international collaborations

Four researchers explain how working with colleagues overseas has helped them to produce stronger science.

AGTC Earns $10 Million After Reaching Phase I/II Study Milestone

Applied Genetic Technologies Corporation has earned a $10 million payment from Biogen for reaching a milestone outlined in a collaboration deal the companies signed in 2015.

Injection of vasoactive intestinal peptide into the eye improves corneal transplant survival

A new study in the American Journal of Pathology reports for the first time that injection of neuropeptide vasoactive intestinal peptide (VIP) directly into the eye of mice enhanced corneal graft survival.

High-profile journals put to reproducibility test

Researchers replicated 62% of social-behaviour findings published in Science and Nature — a result matched almost exactly by a prediction market.

Doctors remove contact lens embedded in eyelid for years

Doctors recently removed a contact lens that was embedded in a woman's eyelid for nearly three decades after she was hit in the eye while playing badminton.

£3.5-million grant lost

Top geneticist loses £3.5-million grant in first test of landmark bullying policy

Retinal abnormalities may indicate preclinical Alzheimer's

Retinal microvascular abnormalities are identified in cognitively healthy individuals who have biomarkers positive for Alzheimer's disease (AD), according to a study published in JAMA Ophthalmology.

Dompe’s Oxervate is First Treatment Approved in US for Neurotrophic Keratitis

Oxervate is the first US treatment for this indication and is labeled for use in patients age 2 and older.

INSiGHT identifies unique retinal regulatory genes

Researches at Baylor College of Medicine, Texas Children's Hospital and the Hospital for Sick Children have developed a new platform that enables them to uncover new regulators of retina neurons.